Judith Stift

Judith Stift

Auto-generated profile, based on publicly available information

Judith Stift

Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2014 in Liver International
Verified
Journal Article
Closed access
PDF file
PSPhilipp Schwabl
Philipp Schwabl
SBSimona Bota
Simona Bota
PSPetra Salzl
Petra Salzl
MMMattias Mandorfer
Mattias Mandorfer
BPBerit A. Payer
Berit A. Payer
TRThomas Reiberger
Thomas Reiberger

15 June 2012 in Wiener klinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
TRThomas Reiberger
Thomas Reiberger
AFArnulf Ferlitsch
Arnulf Ferlitsch
BPBerit Anna Payer
Berit Anna Payer
MPMatthias Pinter
Matthias Pinter
PSPhilipp Schwabl
Philipp Schwabl
MPMarkus Peck-Radosavljevic
Markus Peck-Radosavljevic

1 October 2015 in Radiology
Verified
Journal Article
Closed access
ABAhmed Ba-Ssalamah
Ahmed Ba-Ssalamah
CACélia Antunes
Célia Antunes
DFDiana Feier
Diana Feier
NBNina Bastati
Nina Bastati
JHJacqueline C. Hodge
Jacqueline C. Hodge
FCFilipe Caseiro-Alves
Filipe Caseiro-Alves
To evaluate the diagnostic performance of imaging features of gadoxetic acid-enhanced magnetic resonance (MR) imaging to differentiate among hepatocellular adenoma (HCA) subtypes by using the histopathologic results of the new immunophenotype and genotype classification and to correlate the enhancement pattern on the hepatobiliary phase (HBP) with the degrees of expression of organic anion transporting polypeptide (OATP1B1/3), multidrug resistance-associated protein 2 (MRP) (MRP2), and MRP 3 (MRP3) transporters. This retrospective study was approved by the institutional review board, and the requirement for informed consent waived. MR imaging findings of 29 patients with 43 HCAs were assessed by two radiologists independently then compared with the histopathologic analysis as the standard of reference. Receiver operating characteristic curves and Spearman rank correlation coefficient were used to test the diagnostic performance of gadoxetic acid-enhanced MR imaging features, which included the retention or washout at HBP and degree of transporter expression. Interreader agreement was assessed by using the κ statistic with 95% confidence interval. The area under the curve for the diagnosis of inflammatory HCA was 0.79 (95% confidence interval: 0.64, 0.90); for the steatotic type, it was 0.90 (95% confidence interval: 0.77, 0.97); and for the β-catenin type, it was 0.87 (95% confidence interval: 0.74, 0.95). There were no imaging features that showed a significant statistical correlation for the diagnosis of unclassified HCAs. On immunohistochemical staining, OATP1B1/3 expression was the main determinant for the retention, whereas MRP3 was the key determinant for washout of gadoxetic acid at HBP (P < .001). MRP2 appeared to have no role. Gadoxetic acid-enhanced MR imaging features may suggest the subtype of HCA. The degree of OATP1B1/3 and MRP3 expression correlated statistically with gadoxetic acid retention and washout, respectively, in the HBP.

6 June 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AMAnastasia Meshcheryakova
Anastasia Meshcheryakova
DTDietmar Tamandl
Dietmar Tamandl
EBErika Bajna
Erika Bajna
JSJudith Stift
Judith Stift
MMMartina Mittlboeck
Martina Mittlboeck
DMDiana Mechtcheriakova
Diana Mechtcheriakova
Remarkably limited information is available about biological mechanisms that determine the disease entity of metastatic colorectal cancer in the liver (CRCLM) with no good clinical parameters to estimate prognosis. For the last few years, understanding the relationship between tumor characteristics and local immune response has gained increasing attention. Given the multifaceted roles of B-cell-driven responses, we aimed to elucidate the immunological imprint of B lymphocytes at the metastatic site, the interrelation with macrophages, and their prognostic relevance. Here we present novel algorithm allowing to assess a link between the local patient-specific immunological capacity and clinical outcome. The microscopy-based imaging platform was used for automated scanning of large-scale tissue sections and subsequent qualitative and quantitative analyses of immune cell subtypes using lineage markers and single-cell recognition strategy. Results indicate massive infiltration of CD45-positive leukocytes confined to the metastatic border. We report for the first time the accumulation of CD20-positive B lymphocytes at the tumor – liver interface comprising the major population within the large CD45-positive aggregates. Strikingly, functionally active, activation-induced cytidine deaminase (AID)-positive ectopic lymphoid structures were found to be assembled within the metastatic margin. Furthermore, the CD20-based data set revealed a strong prognostic power: patients with high CD20 content and/or ectopic follicles had significantly lower risk for disease recurrence as revealed by univariate analysis (p<0.001 for both) and in models adjusted for clinicopathological variables (p<0.001 and p = 0.01, respectively), and showed prolonged overall survival. In contrast, CD68 staining-derived data set did not show an association with clinical outcome. Taken together, we nominate the magnitude of B lymphocytes, including those organized in ectopic follicles, as novel prognostic marker which is superior to clinicopathological parameters. Findings emphasize anti-tumoral role of B cell-driven mechanism(s) and thus indicate a new way of thinking about potential treatment strategies for CRCLM patients.

1 October 2013 in European Journal of Radiology
Verified
Journal Article
Closed access
ABAhmed Ba-Ssalamah
Ahmed Ba-Ssalamah
DMDina Muin
Dina Muin
RSRuediger Schernthaner
Ruediger Schernthaner
CKChristiana Kulinna-Cosentini
Christiana Kulinna-Cosentini
NBNina Bastati
Nina Bastati
Marius MayerhoeferMarius Mayerhoefer
Marius Mayerhoefer

1 July 2015 in Journal of Hepatology
Verified
Journal Article
Closed access
ASAlbert Friedrich Stättermayer
Albert Friedrich Stättermayer
STStefan Traussnigg
Stefan Traussnigg
HDHans-Peter Dienes
Hans-Peter Dienes
EAElmar Aigner
Elmar Aigner
RSRudolf Stauber
Rudolf Stauber
PFPeter Ferenci
Peter Ferenci